GAB2 regulates lipid metabolism by activating the MEK/ERK/c-Myc pathway: impact on renal cell carcinoma progression
GAB2 enhances lipid accumulation by activating MEK/ERK/c-Myc pathway, thereby promoting RCC progression. GAB2 is a potential target for RCC management.
Authors
- Nan Huang (ORCID: https://orcid.org/0000-0001-7237-5344)
- Pu Qin
- Weiqun Zhang
- Ting Liu
- Zhipeng Li
- Zhiying Zhu
- Xiaoying Li
- Yan Sun
- Xianming Fei
Institutions
- Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine (CN)
- Hangzhou Medical College (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2025-12-24
- DOI
- https://doi.org/10.1186/s40001-025-03654-5
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00